Folgen
Sharon J Peacock
Sharon J Peacock
Bestätigte E-Mail-Adresse bei medschl.cam.ac.uk - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review
WJ Wiersinga, A Rhodes, AC Cheng, SJ Peacock, HC Prescott
Jama 324 (8), 782-793, 2020
62782020
Multilocus Sequence Typing for Characterization of Methicillin-Resistant and Methicillin-Susceptible Clones ofStaphylococcus aureus
MC Enright, NPJ Day, CE Davies, SJ Peacock, BG Spratt
Journal of clinical microbiology 38 (3), 1008-1015, 2000
38412000
SARS-CoV-2 variants, spike mutations and immune escape
WT Harvey, AM Carabelli, B Jackson, RK Gupta, EC Thomson, ...
Nature Reviews Microbiology 19 (7), 409-424, 2021
33182021
Estimated transmissibility and impact of SARS-CoV-2 lineage B. 1.1. 7 in England
NG Davies, S Abbott, RC Barnard, CI Jarvis, AJ Kucharski, JD Munday, ...
Science 372 (6538), eabg3055, 2021
25972021
Evolution of MRSA during hospital transmission and intercontinental spread
SR Harris, EJ Feil, MTG Holden, MA Quail, EK Nickerson, N Chantratita, ...
Science 327 (5964), 469-474, 2010
12842010
Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance
MTG Holden, EJ Feil, JA Lindsay, SJ Peacock, NPJ Day, MC Enright, ...
Proceedings of the National Academy of Sciences 101 (26), 9786-9791, 2004
12292004
Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study
L García-Álvarez, MTG Holden, H Lindsay, CR Webb, DFJ Brown, ...
The Lancet infectious diseases 11 (8), 595-603, 2011
12092011
Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity
E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ...
Cell 184 (1), 64-75. e11, 2021
11202021
Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis
D Limmathurotsakul, N Golding, DAB Dance, JP Messina, DM Pigott, ...
Nature microbiology 1 (1), 1-5, 2016
10002016
SARS-CoV-2 evolution during treatment of chronic infection
SA Kemp, DA Collier, RP Datir, IATM Ferreira, S Gayed, A Jahun, ...
Nature 592 (7853), 277-282, 2021
9792021
Melioidosis
WJ Wiersinga, BJ Currie, SJ Peacock
New England Journal of Medicine 367 (11), 1035-1044, 2012
9562012
Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei
MTG Holden, RW Titball, SJ Peacock, AM Cerdeño-Tárraga, T Atkins, ...
Proceedings of the National Academy of Sciences 101 (39), 14240-14245, 2004
9402004
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study
KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ...
The Lancet Infectious Diseases 22 (1), 35-42, 2022
8562022
Emergence and global spread of epidemic healthcare-associated Clostridium difficile
M He, F Miyajima, P Roberts, L Ellison, DJ Pickard, MJ Martin, TR Connor, ...
Nature genetics 45 (1), 109-113, 2013
8382013
SARS-CoV-2 variant biology: immune escape, transmission and fitness
AM Carabelli, TP Peacock, LG Thorne, WT Harvey, J Hughes, SJ Peacock, ...
Nature Reviews Microbiology 21 (3), 162-177, 2023
8192023
How Clonal Is Staphylococcus aureus?
EJ Feil, JE Cooper, H Grundmann, DA Robinson, MC Enright, T Berendt, ...
Journal of bacteriology 185 (11), 3307-3316, 2003
8152003
Virulent Combinations of Adhesin and Toxin Genes in Natural Populations of Staphylococcus aureus
SJ Peacock, CE Moore, A Justice, M Kantzanou, L Story, K Mackie, ...
Infection and immunity 70 (9), 4987-4996, 2002
8132002
Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak
CU Köser, MTG Holden, MJ Ellington, EJP Cartwright, NM Brown, ...
New England Journal of Medicine 366 (24), 2267-2275, 2012
7932012
Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study
JM Bryant, DM Grogono, D Greaves, J Foweraker, I Roddick, T Inns, ...
The Lancet 381 (9877), 1551-1560, 2013
7692013
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial
KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ...
The Lancet 397 (10282), 1351-1362, 2021
7572021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20